Skip to main content
. 2019 May 10;11:1758835919833867. doi: 10.1177/1758835919833867

Table 2.

Factors related to TdP development.

Female sex
Bradycardia
Hypokalaemia
Heart failure
Ventricular hypertrophy
Recent cardioversion from atrial fibrillation
High concentration of the drug with known, possible or conditional risk of TdP
Baseline QTc prolongation
Rapid rate of infusion of QTc-prolonging drug
Subclinical long QTc syndrome
Ion channel polymorphisms
Severe hypomagnesaemia